Enrique Uless Zumaeta Saavedra

Enrique Uless Zumaeta Saavedra

Auto-generated profile, based on publicly available information

Enrique Uless Zumaeta Saavedra

Universidad Continental, Lima, Peru

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2023 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MMMoisés Sihuincha Maldonado
Moisés Sihuincha Maldonado
ALAldo Javier Lucchetti
Aldo Javier Lucchetti
RPRaisa Alessandra Paredes Pacheco
Raisa Alessandra Paredes Pacheco
LCLeonel Christian Martínez Cevallos
Leonel Christian Martínez Cevallos
ESEnrique Uless Zumaeta Saavedra
Enrique Uless Zumaeta Saavedra
EDUARDO MATOSEDUARDO MATOS
EDUARDO MATOS
Monkeypox (Mpox) recent outbreak has changed in terms of predominant transmission route and typical presentation. Describing current epidemiological and clinical characteristics is crucial to identifying cases and halting transmission. An observational study was conducted at a Peruvian tertiary-level hospital and included all individuals with Mpox virus infection between July 01 and September 03, 2022. Among 205 confirmed cases, 99% (202/205) were men, 94% (192/205) were men who have sex with men or bisexual, and 66% (136/205) were living with HIV. Regarding sexual behavior, 87% (179/205) had a sexual encounter 21 days before consultation, although only 8% (17/205) identified sexual contact with a Mpox confirmed case; 65% (133/205) had sexual intercourse with casual partners, 55% (112/205) reported a last sexual partner unknown, and 21.5% (44/205) continued having sexual intercourse with symptoms. Systemic symptoms were fever (162/205, 79%), malaise (123/205, 60%), headache (119/205, 58%), fatigue (105/205, 52%), and lymphadenopathy (111/205, 54%). The distribution of skin lesions was generalized (166/205, 81%), located in the anogenital area (160/205, 78%), polymorphic (174/205, 85%), and it was the first symptom identified in 46% (94/205) of cases. Overall, 10% (21/205) required hospitalization, of whom 85.7% (18/205) have HIV infection. Complications included bacterial superinfection (n = 18), proctitis (n = 6), balanitis (n = 4), and necrosis of skin lesions (n = 3). In 2022, Mpox mainly affects men who have sex with men and People living with HIV/AIDS. It presents with skin lesions localized to the anogenital area and can lead to severe complications requiring hospitalization.

24 March 2023 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
EZEnrique Zumaeta-Saavedra
Enrique Zumaeta-Saavedra
CCChristian Chiara-Chilet
Christian Chiara-Chilet
JMJulio Maquera-Afaray
Julio Maquera-Afaray
MLMedalit Luna-Vilchez
Medalit Luna-Vilchez
La papilomatosis respiratoria recurrente es una enfermedad neoplásica causada por el virus del papilomahumano y caracterizada por el crecimiento de lesiones proliferativas exofíticas que afectan la mucosa de las vías respiratorias. En su epidemiología se presenta una distribución bimodal, con una forma juvenil en menores de 20 años, más agresiva, con múltiples lesiones apilomatosas y alta frecuencia de recurrencia, en comparación con la forma adulta. El compromiso pulmonar es poco frecuente y su manejo es un desafío. Se presenta el caso de un varón de 13 años con antecedente de papilomatosis laríngea desde los dos años. El paciente mostró dificultad respiratoria y múltiples nódulos estenosantes en laringe y tráquea, y varios quistes pulmonares visualizados en la tomografía de tórax. Se le realizó exéresis de las lesionespapilomatosas y traqueostomía. Recibió dosis única de bevacizumab 400 mg intravenoso y terapias respiratoriascon evolución favorable, sin recurrencias en el seguimiento.